NANOLIGENT
Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l'Hospital de la Santa Creu I Sant Pau. We are dedicated to drug design and development of targeted-therapeutic biologics .Nanoligent mision is to improve the life of patients by designing new medicines that selectively target the cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.
NANOLIGENT
Industry:
Biotechnology Nanotechnology Pharmaceutical
Founded:
2017-03-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.nanoligent.com
Status:
Active
Total Funding:
1000 K EUR
Technology used in webpage:
SPF Content Delivery Network YouTube Pixabay Arsys.es Arsys DNS
Similar Organizations
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Investors List
AVANTECA Partners
AVANTECA Partners investment in Seed Round - Nanoligent
IAG Capital Partners
IAG Capital Partners investment in Seed Round - Nanoligent
Official Site Inspections
http://www.nanoligent.com
- Host name: llgn180.servidoresdns.net
- IP address: 217.76.130.226
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
